Geron Corp (GERN)
Publicly reported company facts and saved market data for Geron Corp (GERN), with sources and as-of times. Saved data is not a live quote.
Company profile
Geron is a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer. Because patients cannot wait, we approach our work with urgency, bringing together deep expertise in telomerase biology with patient perspectives and insights from clinical research and real-world care. Our medicine, RYTELO (imetelstat), is approved in the United States and European Union for certain patients with lower-risk myelodysplastic syndromes (LR-MDS). We are building on our foundation in telomerase inhibition by studying imetelstat in myelofibrosis, including a pivotal Phase 3 clinical trial in patients with JAK-inhibitor relapsed/refractory disease, as well as other hematologic malignancies. Geron is a commercial-stage company with offices in Parsippany, New Jersey and Foster City, California.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $571.8M · as of
- Incorporated in
- United States
- Company website
- www.geron.com
- Exchange
- NASDAQ
Saved quote
Saved snapshot, not a real-time quote. Check the market time before relying on it.
- Last reported price
- $0.8901
- Reported change
- -5.93%
- Reported volume
- 18,809,057
- Latest market time
Float and shares outstanding
| Measure | Shares | As of | Source and basis |
|---|---|---|---|
| Float | 626,732,812 | Reported by a single source; not cross-checked. | |
| Shares outstanding (O/S) | 642,473,409 | SEC 10-Q filing · filed |
Dates are measurement dates, not the time FennEdge retrieved the data. Float references are listed separately; they are not averaged or adjusted for later splits or share issuances.
Short interest
- Reported short interest
- 74,608,604 shares
- Settlement date
- Source
- Market and company data
Exchange-published short interest for the stated settlement date, not a live short position.
Recent daily sessions
The 10 most recent saved daily sessions, through . Daily OHLC and volume; not real-time.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 1.04 | 1.05 | 0.84 | 0.9685 | 81,724,770 | |
| 1.16 | 1.19 | 1.14 | 1.15 | 6,709,313 | |
| 1.12 | 1.17 | 1.10 | 1.15 | 11,089,630 | |
| 1.15 | 1.15 | 1.08 | 1.12 | 11,233,210 | |
| 1.16 | 1.19 | 1.12 | 1.13 | 7,178,600 | |
| 1.24 | 1.24 | 1.14 | 1.16 | 8,915,716 | |
| 1.20 | 1.24 | 1.18 | 1.24 | 3,564,971 | |
| 1.20 | 1.21 | 1.18 | 1.20 | 4,909,640 | |
| 1.24 | 1.24 | 1.17 | 1.17 | 3,957,991 | |
| 1.20 | 1.24 | 1.20 | 1.23 | 5,678,554 |
Dilution timeline
As of
- · S-3ASR · Shelf registration filed
Parsed share counts, prices and warrant terms require Plus or above. Explore plans
Research this company
FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.
Sign in to continue